Malnutrition in patients undergoing hemodialysis: is intradialytic parenteral nutrition the answer?
Patients with end-stage renal disease often experience malnutrition as a result of decreased dietary intake; inadequate dialysis; loss of nutrients into the dialysate; abnormal protein, carbohydrate, and lipid metabolism; and concomitant diseases, which may contribute to an increase in morbidity and mortality. Intradialytic parenteral nutrition (IDPN) is being used to improve nutritional status, in conjunction with other methods of nutritional supplementation. The biggest advantage of IDPN is probably its convenience since it is administered during dialysis treatment and thus does not require additional clinic visits or prolonged dialysis time. Although IDPN has several disadvantages, its ability to improve nutritional status and reduce morbidity and mortality in patients with end-stage renal disease is promising. Well-designed, large-scale, prospective studies are required to confirm its beneficial effects.
How
Priscilla P
PP
Department of Pharmacy Practice, College of Pharmacy, University of Illinois at Chicago, Chicago, Illinois 60612, USA.
Lau
Alan H
AH
D015415:Biomarkers; D006801:Humans; D044342:Malnutrition / Q000209:etiology / Q000628:therapy*; D010288:Parenteral Nutrition; D006435:Renal Dialysis / Q000009:adverse effects*
D015415:Biomarkers